Molecular and Developmental Biology of Neuroblastoma

  • Akira Nakagawara
Part of the Pediatric Oncology book series (PEDIATRICO)


Bone Morphogenetic Protein Notch Signaling Neural Crest Cell Sympathetic Neuron Neuroblastoma Cell Line 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aloyz RS et al. (1998) p53 is essential for developmental neuron death as regulated by the TrkA and p75 neurotrophin receptors. J Cell Biol 143:1691–1703CrossRefPubMedGoogle Scholar
  2. Altaba ARi, Stecca B, Sanchez P (2004) Hedgehog-Gli signaling in brain tumors: stem cells and paradevelopmental programs in cancer. Cancer Lett 204:145–157CrossRefPubMedGoogle Scholar
  3. Axelson H (2004) The Notch signaling cascade in neuroblastoma: role of the basic helix-loop-helix proteins HASH-1 and HES-1. Cancer Lett 204:171–178CrossRefPubMedGoogle Scholar
  4. Azar CG, Scavarda NJ, Reynolds P, Brodeur GM (1990) Multiple defects of the nerve growth factor receptor in human neuroblastomas. Cell Growth Differ 1:421–428Google Scholar
  5. Ball DW (2004) Achaete-scute homolog-1 and Notch in lung neuroendocrine development and cancer. Cancer Lett 159–169Google Scholar
  6. Billon N et al. (2004) Roles for p53 and p73 during oligodendrocyte development. Development 131:1211–1220CrossRefPubMedGoogle Scholar
  7. Boon K et al. (2001) N-MYC enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis. EMBO J 20:1383–1393CrossRefPubMedGoogle Scholar
  8. Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM (1984) Amplification of N-MYC in untreated human neuroblastomas correlates with advanced disease stage. Science 224:1121–1124PubMedGoogle Scholar
  9. Canete A, Navarro S, Bermudez J, Pellin A, Castel V, Llombart-Bosch A (2000) Angiogenesis in neuroblastoma: relationship to survival and other prognostic factors in a cohort of neuroblastoma patients. J Clin Oncol 18:2789–2791PubMedGoogle Scholar
  10. Deguin-Chambon V, Vacher M, Jullien M, May E, Bourdon JC (2000) Direct transactivation of c-Ha-Ras gene by p53: evidence for its involvement in p53 transactivation activity and p53-mediated apoptosis. Oncogene 19:5831–5841CrossRefPubMedGoogle Scholar
  11. Eggert A et al. (2000) Molecular dissection of TrkA signal transduction pathways mediating differentiation in human neuroblastoma cells. Oncogene 19:2043–2051CrossRefPubMedGoogle Scholar
  12. Eggert A et al. (2001) Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression. Cancer Res 61:1314–1319PubMedGoogle Scholar
  13. El-Badry OM, Helman LJ, Chatten J, Steinberg SM, Evans AE, Israel MA (1991) Insulin-like growth factor II-mediated proliferation of human neuroblastoma. J Clin Invest 87: 648–657PubMedGoogle Scholar
  14. Enomoto H et al. (1994) Identification of human DAN gene, mapping to the putative neuroblastoma tumor suppressor locus. Oncogene 9:2785–2791PubMedGoogle Scholar
  15. Ernsberger U (2000) Evidence for an evolutionary conserved role of bone morphogenetic protein growth factors and phox2 transcription factors during noradrenergic differentiation of sympathetic neurons. Induction of a putative synexpression group of neurotransmitter-synthesizing enzymes. Eur J Biochem 267:6976–6981CrossRefPubMedGoogle Scholar
  16. Guillemot F, Lo LC, Johnson JE, Auerbach A, Anderson DJ, Joyner AL (1993) Mammalian achaete-scute homolog 1 is required for the early development of olfactory and autonomic neurons. Cell 75:463–476CrossRefPubMedGoogle Scholar
  17. Hamano S, Ohira M, Isogai E, Nakada K, Nakagawara A (2004) Identification of novel human neuronal leucine-rich repeat (hNLRR) family genes and inverse association of expression of Nbla10449/hNLRR-1 and Nbla10677/hNLRR-3 with the prognosis of primary neuroblastomas. Int J Oncol 24:1457–1466PubMedGoogle Scholar
  18. Hishiki T et al. (1998) Glial cell line-derived neurotrophic factor/neurturin-induced differentiation and its enhancement by retinoic acid in primary human neuroblastomas expressing c-Ret, GFR-1 and GFR-2. Cancer Res 58:2158–2165PubMedGoogle Scholar
  19. Huang EJ, Reichardt LF (2003) Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem 72:609–642CrossRefPubMedGoogle Scholar
  20. Huber K, Combs S, Ernsberger U, Kalcheim C, Unsicker K (2002) Generation of neuroendocrine chromaffin cells from sympathoadrenal progenitors: beyond the glucocorticoid hypothesis. Ann NY Acad Sci 971:554–559PubMedGoogle Scholar
  21. Hughes AL, Gollapudi L, Sladek TL, Neet KE (2000) Mediation of nerve growth factor-driven cell cycle arrest in PC12 cells by p53: simultaneous differentiation and proliferation subsequent to p53 functional inactivation. J Biol Chem 275:37829–37837CrossRefPubMedGoogle Scholar
  22. Iavarone A, Lasorella A (2004) Id proteins in neural cancer. Cancer Lett 204:189–196CrossRefPubMedGoogle Scholar
  23. Ichikawa M, Murakumo Y, Takahashi M (2004) RET and neuroendocrine tumors. Cancer Lett 204:197–211CrossRefPubMedGoogle Scholar
  24. Ichimiya S et al (1999) p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent. Oncogene 18:1061–1066CrossRefPubMedGoogle Scholar
  25. Ichimiya S, Nimura Y, Seki N, Ozaki T, Nagase T, Nakagawara A (2001) Down-regulation of hASH1 is associated with the retinoic acid-induced differentiation of human neuroblastoma cell lines. Med Pediatr Oncol 36:132–134CrossRefPubMedGoogle Scholar
  26. Ikeda H et al. (1995) Bcl-2 oncoprotein expression and apoptosis in neuroblastoma. J Pediatr Surg 30:805–808CrossRefPubMedGoogle Scholar
  27. Ikegaki N, Katsumata M, Tsujimoto Y, Nakagawara A, Brodeur GM (1995) Relationship between bcl-2 and MYC gene expression in human neuroblastoma. Cancer Lett 91:161–168CrossRefPubMedGoogle Scholar
  28. Islam A et al (2000) High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma. Oncogene 19:617–623CrossRefPubMedGoogle Scholar
  29. Kadomatsu K, Muramatsu T (2004) Midkine and pleiotrophin in neural development and cancer. Cancer Lett 204:127–143CrossRefPubMedGoogle Scholar
  30. Kadomatsu K, Huang R-P, Suganuma T, Murata F, Muramatsu T (1990) A retinoic acid responsive gene MK found in the teratocarcinoma system is expressed in spatially and temporally controlled manner during mouse embryogenesis. J Cell Biol 110:607–616CrossRefPubMedGoogle Scholar
  31. Kawamoto T, Ohira M, Hamano S, Hori T, Nakagawara A (2003) High expression of the novel endothelin-converting enzyme genes, Nbla03145/ECEL1alpha and beta is associated with favorable prognosis in human neuroblastomas. Int J Oncol 22:815–822PubMedGoogle Scholar
  32. Kitanaka C et al (2002) Increased Ras expression and caspase-independent neuroblastoma cell death: possible mechanism of spontaneous neuroblastoma regression. J Natl Cancer Inst 94:358–368PubMedGoogle Scholar
  33. Klein R (1994) Role of neurotrophins in mouse neuronal development. FASEB J 8:738–744PubMedGoogle Scholar
  34. Klesse LJ, Parada LF (1999) Trks: signal transduction and intracellular pathways. Microsc Res Tech 45:210–216CrossRefPubMedGoogle Scholar
  35. Kogner P, Barbany G, Dominici C, Castello MA, Raschella G, Persson H (1993) Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis. Cancer Res 53:2044–2050PubMedGoogle Scholar
  36. Lasorella A, Noseda M, Beyna M, Yokota Y, Iavarone A (2000) Id2 is a retinoblastoma protein target and mediates signalling by MYC oncoproteins. Nature 407:592–598CrossRefPubMedGoogle Scholar
  37. Laurenzi VD et al. (2000) Induction of neuronal differentiation by p73 in a neuroblastoma cell line. J Biol Chem 275:15226–15231CrossRefPubMedGoogle Scholar
  38. Li Y-S et al. (1990) Cloning and expression of a developmentally regulated protein that induces mitogenic and neurite outgrowth activity. Science 250:1690–1694PubMedGoogle Scholar
  39. Lo L, Morin X, Brunet JF, Anderson DJ (1999) Specification of neurotransmitter identity by Phox2 proteins in neural crest stem cells. Neuron 22:693–705CrossRefPubMedGoogle Scholar
  40. Mac SM, D'Cunha CA, Farnham PJ (2000) Direct recruitment of N-MYC to target gene promoters. Mol Carcinogr 29:76–86CrossRefGoogle Scholar
  41. Massari ME, Murre C (2000) Helix-loop-helix proteins: regulators of transcription in eukaryotic organisms. Mol Cell Biol 20:429–440CrossRefPubMedGoogle Scholar
  42. Matsumoto K, Wada RK, Yamashiro JM, Kaplan DR, Thiele CJ (1995) Expression of brain-derived neurotrophic factor and p145TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells. Cancer Res 55:1798–1806PubMedGoogle Scholar
  43. Moll UM, LaQuaglia M, Benard J, Riou G (1995) Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors. Proc Natl Acad Sci USA 92:4407–4411PubMedGoogle Scholar
  44. Morin X, Cremer H, Hirsch MR, Kapur RP, Goridis C, Brunet JF (1997) Defects in sensory and autonomic ganglia and absence of locus coeruleus in mice deficient for the homeobox gene Phox2a. Neuron 18:411–423PubMedGoogle Scholar
  45. Nakagawa T et al (2002) Autoinhibitory regulation of p73 by ‡Np73 to modulate cell survival and death through p73-specific target element within the ‡Np73 promoter. Mol Cell Biol 22:2575–2585CrossRefPubMedGoogle Scholar
  46. Nakagawara A (1998a) The NGF story and neuroblastoma. Med Pediatr Oncol 31:113–115CrossRefPubMedGoogle Scholar
  47. Nakagawara A (1998b) Molecular basis of spontaneous regression of neuroblastoma: role of neurotrophic signals and genetic abnormalities. Hum Cell 11:115–124PubMedGoogle Scholar
  48. Nakagawara A (2001) Trk receptor tyrosine kinases: a bridge between cancer and neural development. Cancer Lett 169:107–114CrossRefPubMedGoogle Scholar
  49. Nakagawara A (2004) Neural crest development and neuroblastoma: the genetic and biological link. In: Aloe L, Calza L (eds) NGF and related molecules in health and disease. Elsevier, Amsterdam, pp 233–242Google Scholar
  50. Nakagawara A, Arima M, Azar CG, Scavarda NJ, Brodeur GM (1992) Inverse relationship between trk expression and N-MYC amplification in human neuroblastomas. Cancer Res 52:1364–1368PubMedGoogle Scholar
  51. Nakagawara A, Arima-Nakagawara M, Scavarda NJ, Azar CG, Cantor AB, Brodeur GM (1993) Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N Engl J Med 328:847–854CrossRefPubMedGoogle Scholar
  52. Nakagawara A, Azar CG, Scavarda NJ, Brodeur GM (1994) Expression and function of TRK-B and BDNF in human neuroblastomas. Mol Cell Biol 14:759–767PubMedGoogle Scholar
  53. Nakagawara A et al. (1995) Differential expression of pleiotrophin and midkine in advanced neuroblastomas. Cancer Res 55:1792–1797PubMedGoogle Scholar
  54. Nakagawara A et al. (1997) High levels of expression and nuclear localization of ICE and CPP32 in favorable human neuroblastomas. Cancer Res 57:4578–4584PubMedGoogle Scholar
  55. Nakamura Y, Ozaki T, Koseki H, Nakagawara A, Sakiyama S (2003) Accumulation of p27KIP1 is associated with BMP2-mediated growth arrest and neuronal differentiation of human neuroblastoma-derived cell lines. Biochem Biophys Res Commun 307:206–213CrossRefPubMedGoogle Scholar
  56. Oppenheim RW (1991) Cell death during development of the nervous system. Annu Rev Neurosci 14:453–501CrossRefPubMedGoogle Scholar
  57. Pattyn A, Morin X, Cremer H, Goridis C, Brunet JF (1999) The homeobox gene Phox2b is essential for the development of autonomic neural crest derivatives. Nature 399:366–370CrossRefPubMedGoogle Scholar
  58. Pozniak CD, Radinovic S, Yang A, McKeon F, Kaplan DR, Miller FD (2000) An anti-apoptotic role for the p53 family member, p73, during developmental neuron death. Science 289:304–306CrossRefPubMedGoogle Scholar
  59. Radtke F, Raj K (2003) The role of Notch in tumorigenesis: oncogene or tumour suppressor? Nat Rev Cancer 3:756–767CrossRefPubMedGoogle Scholar
  60. Reale MA et al. (1996) Loss of DCC expression in neuroblastoma is associated with disease dissemination. Clin Cancer Res 2:1097–1102PubMedGoogle Scholar
  61. Rodriguez-Leon J, Merino R, Macias D, Ganan Y, Santesteban E, Hurle JM (1999) Retinoic acid regulates programmed cell death through BMP signalling. Nat Cell Biol 1:125–126CrossRefPubMedGoogle Scholar
  62. Schneider C, Wicht H, Enderich J, Wegner M, Rohrer H (1999) Bone morphogenetic proteins are required in vivo for the generation of sympathetic neurons. Neuron 24:861–870CrossRefPubMedGoogle Scholar
  63. Schwab M et al. (1983) Amplified DNA with limited homology to MYC cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature 305:245–248CrossRefPubMedGoogle Scholar
  64. Schwab M et al (1984) Chromosome localization in normal human cells and neuroblastomas of a gene related to c-MYC. Nature 308:288–291CrossRefPubMedGoogle Scholar
  65. Schwab M et al. (2003) Neuroblastoma: biology and molecular and chromosomal pathology. Lancet Oncol 4:472–480CrossRefPubMedGoogle Scholar
  66. Schweigerer L, Ledoux D, Fleischmann G, Barritault D (1991) Enhanced MYCN oncogene expression in human neuroblastoma cells is associated with altered FGF receptor expression and cellular growth response to basic FGF. Biochem Biophys Res Commun 179:1449–1454CrossRefPubMedGoogle Scholar
  67. Seeger RC et al. (1985) Association of multiple copies of the N-MYC oncogene with rapid progression of neuroblastomas. N Engl J Med 313:1111–1116PubMedGoogle Scholar
  68. Shinbo J et al. (2002) p73-dependent expression of DAN during cisplatin-induced cell death and osteoblast differentiation. Biochem Biophys Res Commun 295:501–507CrossRefPubMedGoogle Scholar
  69. Snider WD (1994) Functions of the neurotrophins during nervous system development: what the knockouts are teaching us. Cell 77:627–638CrossRefPubMedGoogle Scholar
  70. Soderholm H et al. (1999) Human achaete-scute homologue 1 (HASH-1) is downregulated in differentiating neuroblastoma cells. Biochem Biophys Res Commun 256:557–563CrossRefPubMedGoogle Scholar
  71. Stanke M, Junghans D, Geissen M, Goridis C, Ernsberger U, Rohrer H (1999) The Phox2 homeodomain proteins are sufficient to promote the development of sympathetic neurons. Development 126:4087–4094PubMedGoogle Scholar
  72. Suzuki T, Bogenmann E, Shimada H, Stram D, Seeger RC (1993) Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas. J Natl Cancer Inst 85:377–384PubMedGoogle Scholar
  73. Teitz T et al (2000) Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat Med 6:529–535CrossRefPubMedGoogle Scholar
  74. Tian H, Hammer RE, Matsumoto AM, Russell DW, McKnight SL (1998) The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development. Genes Dev 12:3320–3324PubMedGoogle Scholar
  75. Trochet D et al (2004) Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma. Am J Hum Genet 74:761–764CrossRefPubMedGoogle Scholar
  76. Tweddle DA, Malcolm AJ, Bown N, Pearson AD, Lunec J (2001) Evidence for the development of p53 mutations after cytotoxic therapy in a neuroblastoma cell line. Cancer Res 61:8–13PubMedGoogle Scholar
  77. Van Noesel MM, Pieters R, Voute PA, Versteeg R (2003) The N-MYC paradox: N-MYC overexpression in neuroblastomas is associated with sensitivity as well as resistance to apoptosis. Cancer Lett 197:165–172CrossRefPubMedGoogle Scholar
  78. Yamashiro D, Nakagawara A, Ikegaki N, Liu X, Brodeur GM (1996) Expression of TRK-C in favorable human neuroblastomas. Oncogene 12:37–41PubMedGoogle Scholar
  79. Yang A, Walker N, Bronson R, Kaghad M, Oosterwegel M, Bonnin J, Vagner C, Bonnet H, Dikkes P, Sharpe A, McKeon F, Caput D (2000) p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature 404:99–103CrossRefPubMedGoogle Scholar
  80. Yano H, Cong F, Birge RB, Goff SP, Chao MV (2000) Association of the Abl tyrosine kinase with the Trk nerve growth factor receptor. J Neurosci Res 59:356–364CrossRefPubMedGoogle Scholar
  81. Yoshida I, Koide S, Nakagawara A, Tsuji A, Matsuda Y (2001) Proprotein convertase PACE4 is a target gene of the basic helix-loop-helix transcription factor hASH-1. Biochem J 360:683–689CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • Akira Nakagawara

There are no affiliations available

Personalised recommendations